China SXT Pharmaceuticals, Inc. Capital Expenditures
China SXT Pharmaceuticals, Inc. (SXTC) reported Capital Expenditures of $2.02 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-01
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|
| 2025-03-31 | $2.02K 20-F · filed 2026-07-01 | |
| 2024-03-31 | $7.06K 20-F · filed 2026-07-01 | |
| 2020-03-31 | $130.84K 20-F · filed 2020-07-31 | |
| 2019-09-30 | $123.54K 6-K/A · filed 2020-05-22 | |
| 2019-03-31 | $535.83K 20-F · filed 2020-07-31 | |
| 2018-09-30 | $84.40K 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | $436.02K 20-F · filed 2020-07-31 | |
| 2017-03-31 | $179.18K 20-F · filed 2019-08-15 |